Abstract
OBJECTIVE: To assess the contribution of maternal and placental factors to the development of superimposed preeclampsia in women with chronic hypertension.
METHODS: Endothelial and renal function markers were serially assessed in 90 pregnant women with chronic hypertension and controls.
RESULTS: Syndecan-1 concentrations were lower at 26-27+6 weeks in women with chronic hypertension who subsequently developed superimposed preeclampsia compared with those who did not. Decreased PlGF and raised urine albumin:creatinine ratio were also associated with development of superimposed preeclampsia.
CONCLUSION: Decreased syndecan-1 and PlGF concentrations implicate endothelial glycocalyx disturbance and reduced placental angiogenic capacity, respectively, in the pathophysiology of superimposed preeclampsia.
Original language | English |
---|---|
Pages (from-to) | 326-335 |
Number of pages | 10 |
Journal | HYPERTENSION IN PREGNANCY |
Volume | 39 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2020 |
Publication type | A1 Journal article-refereed |
Keywords
- Adult
- Biomarkers
- Cystatin C/blood
- Female
- Humans
- Hypertension/blood
- Lipocalin-2/blood
- Longitudinal Studies
- Placenta
- Placenta Growth Factor/blood
- Pre-Eclampsia/blood
- Pregnancy
- Prospective Studies
- Vascular Endothelial Growth Factor Receptor-1/blood
Publication forum classification
- Publication forum level 1